Tackling Technology Transfer Challenges in Cell and Gene Therapy: Roberto Formisano Discusses Complexities and Implications

In a video interview, Roberto Formisano, Process Transfer Senior Manager at AGC Biologics, discusses the challenges associated with technology transfer in the cell and gene therapy industry. He highlights the complexities involved in transferring technology from development to GMP manufacturing as well as from a customer to a contract development and manufacturing organization (CDMO).

Roberto emphasizes the critical timelines that present the biggest challenges in technology transfer. He explains how balancing the number of batches that need to be manufactured is essential to ensuring sufficient and scientifically quality data within these timelines.

During his conversation with EPR editor Caroline Peachey at Terrapin’s Advanced Therapies conference in London on 19 March, Roberto delves into the nuances of technology transfer and its implications for the industry. He also shares his insights on the technology and manufacturing trends and priorities that he foresees for the cell and gene therapy industry in 2024.